English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5141]
News [14910]
Articles [105]
Editorials [3]
Conferences [247]
elearning [21]
ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer
ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer
ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer
ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer
‘Game-changing’ immunotherapy doubles head and neck cancer survival
‘Game-changing’ immunotherapy doubles head and neck cancer survival
ESMO 2016: Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify responders
ESMO 2016: Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify responders
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
ESMO 2016: Targeting oestrogen receptor improves progression-free survival in advanced breast cancer
ESMO 2016: Targeting oestrogen receptor improves progression-free survival in advanced breast cancer
ESMO 2016: Ribociclib improves progression-free survival in advanced breast cancer
ESMO 2016: Ribociclib improves progression-free survival in advanced breast cancer
<1...11021103110411051106...1491>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top